Aicore
Aicore is a European pharmaceutical company focused on developing, manufacturing, and distributing evidence-based medications. Its mission is to prolong life and improve well-being by providing proven medications and promoting responsible consumption. The company operates in multiple European countries with production sites and representative offices, and has a diverse portfolio of medical products across various branches including otolaryngology, allergology, gastroenterology, pediatrics, and gynecology.
Industries
Nr. of Employees
small (1-50)
Products
NORMARIN SINUS
Non‑medicated nasal irrigation spray containing 2.3% hypertonic sterile seawater for mucus thinning and nasal cavity irrigation; indicated for relief of nasal congestion and removal of particles and allergens.
NORMARIN ALLERGY
Non‑medicated nasal irrigation spray with 2.0% hypertonic sterile saline intended to flush airborne allergens and relieve nasal congestion related to allergic rhinitis and related conditions.
NORMARIN DAILY
Non‑medicated isotonic nasal irrigation spray (0.9% seawater) for routine nasal hygiene and relief of congestion associated with rhinitis, sinusitis, and common cold; suitable from 6 months of age.
NORMARIN BABY
Low‑pressure nasal irrigation spray formulated with physiological seawater and microelements, designed for infants (from 2 months) and adults for relief of nasal congestion; gentle spray for sensitive users.
D-ORS
Single‑use medical device in sachet form containing diosmectite and oral rehydration salts for the treatment and prevention of dehydration associated with acute and chronic diarrhea; indicated from age 2 years and adults.
D-ORS PLUS
Single‑use sachet medical device containing diosmectite, oral rehydration salts, and partially hydrolyzed guar gum as excipient for oral suspension; indicated for diarrhea treatment and prophylaxis during chemo/radiotherapy; suitable from 1 month of age.
NORMARIN SINUS
Non‑medicated nasal irrigation spray containing 2.3% hypertonic sterile seawater for mucus thinning and nasal cavity irrigation; indicated for relief of nasal congestion and removal of particles and allergens.
NORMARIN ALLERGY
Non‑medicated nasal irrigation spray with 2.0% hypertonic sterile saline intended to flush airborne allergens and relieve nasal congestion related to allergic rhinitis and related conditions.
NORMARIN DAILY
Non‑medicated isotonic nasal irrigation spray (0.9% seawater) for routine nasal hygiene and relief of congestion associated with rhinitis, sinusitis, and common cold; suitable from 6 months of age.
NORMARIN BABY
Low‑pressure nasal irrigation spray formulated with physiological seawater and microelements, designed for infants (from 2 months) and adults for relief of nasal congestion; gentle spray for sensitive users.
D-ORS
Single‑use medical device in sachet form containing diosmectite and oral rehydration salts for the treatment and prevention of dehydration associated with acute and chronic diarrhea; indicated from age 2 years and adults.
D-ORS PLUS
Single‑use sachet medical device containing diosmectite, oral rehydration salts, and partially hydrolyzed guar gum as excipient for oral suspension; indicated for diarrhea treatment and prophylaxis during chemo/radiotherapy; suitable from 1 month of age.
Services
Consulting on promotional and distribution strategy, sales tooling, and outsourced marketing activities for medicines, medical devices, skincare, and oral care products in Eastern Europe.
Support to develop registration strategies, prepare submission dossiers, and liaise with local authorities to obtain market authorization.
Protocol design, site identification, clinical regulatory support, and strategic clinical advisory services for clinical studies.
Management of distribution channels, exclusive distribution agreements, and territory-based commercialization for partner products.
Consulting on promotional and distribution strategy, sales tooling, and outsourced marketing activities for medicines, medical devices, skincare, and oral care products in Eastern Europe.
Support to develop registration strategies, prepare submission dossiers, and liaise with local authorities to obtain market authorization.
Protocol design, site identification, clinical regulatory support, and strategic clinical advisory services for clinical studies.
Management of distribution channels, exclusive distribution agreements, and territory-based commercialization for partner products.
Expertise Areas
- Clinical trial management
- Regulatory compliance and market access in Eastern Europe
- Pharmaceutical distribution and commercialization
- Medical device and OTC product distribution
Key Technologies
- Regulatory dossier preparation (marketing authorization submissions)
- Clinical protocol design and trial operations
- Contract manufacturing management
- Hypertonic/isotonic nasal irrigation formulation
News & Updates
In January 2022, marketing authorization was received in Moldova for Airing™, a contraceptive vaginal ring licensed from Mithra (Belgium). Market introduction is expected for the second half of 2023.
Aicore Life Science, Netherlands, obtained marketing authorization in Moldova for Aivial™ in November 2021. Market introductions are expected in the second half of 2023.
Aicore Life Science, Netherlands, obtained marketing authorization in Bulgaria for Aivial™ in November 2021. Market introductions are expected in the second half of 2023.
More news and updates about Aicore's activities and product launches.
In January 2022, marketing authorization was received in Moldova for Airing™, a contraceptive vaginal ring licensed from Mithra (Belgium). Market introduction is expected for the second half of 2023.
Aicore Life Science, Netherlands, obtained marketing authorization in Moldova for Aivial™ in November 2021. Market introductions are expected in the second half of 2023.
Aicore Life Science, Netherlands, obtained marketing authorization in Bulgaria for Aivial™ in November 2021. Market introductions are expected in the second half of 2023.
More news and updates about Aicore's activities and product launches.